Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -8.02 is in line with its 4-year average of -7.51, around the middle of its 4-year range (-34.17–9.31).
68.27% above its 12-month average of -25.27.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.22.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 8 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:35:33.407Z. Historical observations retain their original dates. Historical series through 2024-03-11.
EARNINGS PER SHARE (EPS)
-8.02
EARNINGS PER SHARE (EPS) AVG TTM
-25.27
EARNINGS PER SHARE (EPS) AVG 3Y
-9.38
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+68.27%
CURRENT VS 3Y AVG
+14.50%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aspire Biopharma Holdings, Inc.
Market Cap
$1.02M
Earnings Per Share (EPS)
-8.02
TTM Avg
-25.27
3Y Avg
-9.38
5Y Avg
N/A
Market Cap
$1.06M
Earnings Per Share (EPS)
-89.20
TTM Avg
-39.24
3Y Avg
-1704.73
5Y Avg
-1696.36
Market Cap
$1.10M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.03
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$861915.00
Earnings Per Share (EPS)
-180.45
TTM Avg
-617.40
3Y Avg
-559.80
5Y Avg
-483.70
Market Cap
$874595.00
Earnings Per Share (EPS)
-1.86
TTM Avg
-3.74
3Y Avg
-18.16
5Y Avg
-24.28
Market Cap
$1.18M
Earnings Per Share (EPS)
-19.33
TTM Avg
-12.55
3Y Avg
-11.71
5Y Avg
-15.69
Market Cap
$840509.00
Earnings Per Share (EPS)
-29.09
TTM Avg
-56.46
3Y Avg
-589.82
5Y Avg
-783.52
Market Cap
$1.16M
Earnings Per Share (EPS)
N/A
TTM Avg
-76.17
3Y Avg
-936.34
5Y Avg
-837.30
Market Cap
$825702.00
Earnings Per Share (EPS)
-11.80
TTM Avg
-236.00
3Y Avg
-263.84
5Y Avg
-205.13
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.02M | -8.02 | -25.27 | -9.38 | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | -89.20 | -39.24 | -1704.73 | -1696.36 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | -0.03 | 0.05 | 0.05 |
| GlucoTrack, Inc. (GCTK)vs › | $861915.00 | -180.45 | -617.40 | -559.80 | -483.70 |
| Bone Biologics Corporation (BBLG)vs › | $874595.00 | -1.86 | -3.74 | -18.16 | -24.28 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | -19.33 | -12.55 | -11.71 | -15.69 |
| Decoy Therapeutics Inc. (DCOY)vs › | $840509.00 | -29.09 | -56.46 | -589.82 | -783.52 |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | N/A | -76.17 | -936.34 | -837.30 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $825702.00 | -11.80 | -236.00 | -263.84 | -205.13 |
| Genprex, Inc. (GNPX)vs › | $1.31M | -158.78 | -3127.89 | -13218.44 | -15729.46 |
Trailing EPS (TTM)
$-8.02
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -16.38 |
| 2024-12-31 | -34.17 |
| 2023-12-31 | 9.31 |
| 2022-12-31 | 3.72 |
| 2021-12-31 | -0.04 |
